| Year |
Citation |
Score |
| 2023 |
Ma M, Yang Y, Chen Z, Li X, Yang Z, Wang K, Li X, Fang H, Cheng Y, Qiao T, Zou X, Lu Z, Wang X, Wu D. T-cell senescence induced by peripheral phospholipids. Cell Biology and Toxicology. PMID 37261679 DOI: 10.1007/s10565-023-09811-y |
0.453 |
|
| 2021 |
Liang T, Xue J, Yao Z, Ye Y, Yang X, Hou X, Fang H. Design, synthesis and biological evaluation of 3, 4-disubstituted-imidazolidine-2, 5-dione derivatives as HDAC6 selective inhibitors. European Journal of Medicinal Chemistry. 221: 113526. PMID 33992929 DOI: 10.1016/j.ejmech.2021.113526 |
0.302 |
|
| 2020 |
Liang X, Fu H, Xiao P, Fang H, Hou X. Design, synthesis and biological evaluation of imidazolidine-2,4-dione and 2-thioxothiazolidin-4-one derivatives as lymphoid-specific tyrosine phosphatase inhibitors. Bioorganic Chemistry. 103: 104124. PMID 32768742 DOI: 10.1016/J.Bioorg.2020.104124 |
0.38 |
|
| 2020 |
Du J, Li W, Liu B, Zhang Y, Yu J, Hou X, Fang H. An in silico mechanistic insight into HDAC8 activation facilitates the discovery of new small-molecule activators. Bioorganic & Medicinal Chemistry. 28: 115607. PMID 32690262 DOI: 10.1016/J.Bmc.2020.115607 |
0.338 |
|
| 2020 |
Du J, Liu L, Liu B, Yang J, Hou X, Yu J, Fang H. Structure-based virtual screening, biological evaluation and biophysical study of novel Mcl-1 inhibitors. Future Medicinal Chemistry. PMID 32397829 DOI: 10.4155/Fmc-2020-0114 |
0.423 |
|
| 2020 |
Zhou Y, Liu X, Xue J, Liu L, Liang T, Li W, Yang X, Hou X, Fang H. Discovery of Peptide Boronate Derivatives as Histone Deacetylase (HDAC) and Proteasome Dual Inhibitors for Overcoming Bortezomib Resistance of Multiple Myeloma. Journal of Medicinal Chemistry. PMID 32267687 DOI: 10.1021/Acs.Jmedchem.9B02161 |
0.33 |
|
| 2020 |
Liu L, Liu R, Yang X, Hou X, Fang H. Design, synthesis and biological evaluation of tyrosine derivatives as Mcl-1 inhibitors. European Journal of Medicinal Chemistry. 191: 112142. PMID 32088497 DOI: 10.1016/J.Ejmech.2020.112142 |
0.39 |
|
| 2020 |
Hou X, Sun JP, Ge L, Liang X, Li K, Zhang Y, Fang H. Inhibition of striatal-enriched protein tyrosine phosphatase by targeting computationally revealed cryptic pockets. European Journal of Medicinal Chemistry. 190: 112131. PMID 32078861 DOI: 10.1016/J.Ejmech.2020.112131 |
0.355 |
|
| 2020 |
Du J, Guo J, Kang D, Li Z, Wang G, Wu J, Zhang Z, Fang H, Hou X, Huang Z, Li G, Lu X, Liu X, Ouyang L, Rao L, et al. New techniques and strategies in drug discovery Chinese Chemical Letters. 31: 1695-1708. DOI: 10.1016/J.Cclet.2020.03.028 |
0.374 |
|
| 2019 |
Chen C, Yang X, Fang H, Hou X. Design, synthesis and preliminary bioactivity evaluations of 8-hydroxyquinoline derivatives as matrix metalloproteinase (MMP) inhibitors. European Journal of Medicinal Chemistry. 181: 111563. PMID 31415980 DOI: 10.1016/J.Ejmech.2019.111563 |
0.319 |
|
| 2019 |
Liang T, Hou X, Zhou Y, Yang X, Fang H. Design, Synthesis, and Biological Evaluation of 2,4-Imidazolinedione Derivatives as HDAC6 Isoform-Selective Inhibitors. Acs Medicinal Chemistry Letters. 10: 1122-1127. PMID 31413795 DOI: 10.1021/Acsmedchemlett.9B00084 |
0.407 |
|
| 2019 |
Chen C, Nie Y, Xu G, Yang X, Fang H, Hou X. Design, synthesis and preliminary bioactivity studies of indomethacin derivatives as Bcl-2/Mcl-1 dual inhibitors. Bioorganic & Medicinal Chemistry. PMID 31079964 DOI: 10.1016/J.Bmc.2019.05.003 |
0.361 |
|
| 2019 |
Liu R, Liu L, Yang X, Fang H. Discovery and development of 1,2,3,4-tetrahydroisoquinoline-3-carboxylic acid derivatives as Bcl-2/Mcl-1 inhibitors. Bioorganic Chemistry. 88: 102938. PMID 31028992 DOI: 10.1016/J.Bioorg.2019.102938 |
0.412 |
|
| 2019 |
Li K, Hou X, Li R, Bi W, Yang F, Chen X, Xiao P, Liu T, Lu T, Zhou Y, Tian Z, Shen Y, Zhang Y, Wang J, Fang H, et al. Identification and structure-function analyses of an allosteric inhibitor of the tyrosine phosphatase PTPN22. The Journal of Biological Chemistry. PMID 30979725 DOI: 10.1074/Jbc.Ra118.007129 |
0.391 |
|
| 2019 |
Liu T, Dong G, Xu F, Han B, Fang H, Huang Y, Zhou Y, Du L, Li M. Discovery of Turn-On Fluorescent Probes for Detecting Bcl-2 Protein. Analytical Chemistry. PMID 30859811 DOI: 10.1021/Acs.Analchem.8B05853 |
0.684 |
|
| 2019 |
Li Y, Fang H, Hou Z, Sang L, Yang X. An in-line capillary electrophoresis assay for the high-throughput screening of histone deacetylase inhibitors. Journal of Chromatography. A. PMID 30665742 DOI: 10.1016/J.Chroma.2019.01.025 |
0.329 |
|
| 2018 |
Hou X, Rooklin DW, Yang D, Liang X, Li K, Lu J, Wang C, Xiao P, Zhang Y, Sun JP, Fang H. Computational strategy for bound state structure prediction in structure-based virtual screening: a case study of protein tyrosine phosphatase receptor type O inhibitors. Journal of Chemical Information and Modeling. PMID 30299094 DOI: 10.1021/Acs.Jcim.8B00548 |
0.34 |
|
| 2018 |
Liu R, Liu L, Liu T, Yang X, Wan Y, Fang H. Discovery and development of substituted tyrosine derivatives as Bcl-2/Mcl-1 inhibitors. Bioorganic & Medicinal Chemistry. PMID 30170927 DOI: 10.1016/J.Bmc.2018.08.030 |
0.369 |
|
| 2018 |
Yang D, Xiao P, Li Q, Fu X, Pan C, Lu D, Wen S, Xia W, He D, Li H, Fang H, Shen Y, Xu Z, Lin A, Yu X, et al. Allosteric modulation of the catalytic VYD loop in Slingshot by its N-terminal domain underlies both Slingshot autoinhibition and activation. The Journal of Biological Chemistry. PMID 30154244 DOI: 10.1074/Jbc.Ra118.004175 |
0.331 |
|
| 2018 |
Wan Y, Dai N, Tang Z, Fang H. Small-molecule Mcl-1 inhibitors: Emerging anti-tumor agents. European Journal of Medicinal Chemistry. 146: 471-482. PMID 29407973 DOI: 10.1016/J.Ejmech.2018.01.076 |
0.342 |
|
| 2018 |
Fang G, Wang H, Bian Z, Sun J, Liu A, Fang H, Liu B, Yao Q, Wu Z. Recent development of boronic acid-based fluorescent sensors Rsc Advances. 8: 29400-29427. DOI: 10.1039/C8Ra04503H |
0.342 |
|
| 2017 |
Liu T, Jiang Y, Liu Z, Li J, Fang K, Zhuang C, Du L, Fang H, Sheng C, Li M. Correction: Environment-sensitive turn-on fluorescent probes for p53-MDM2 protein-protein interaction. Medchemcomm. 8: 1727. PMID 30109865 DOI: 10.1039/C7Md90031G |
0.66 |
|
| 2017 |
Liu T, Jiang Y, Liu Z, Li J, Fang K, Zhuang C, Du L, Fang H, Sheng C, Li M. Environment-sensitive turn-on fluorescent probes for p53-MDM2 protein-protein interaction. Medchemcomm. 8: 1668-1672. PMID 30108877 DOI: 10.1039/C7Md00287D |
0.686 |
|
| 2017 |
Liu T, Gao Y, Zhang X, Wan Y, Du L, Fang H, Li M. Discovery of a Turn-On Fluorescent Probe for Myeloid Cell Leukemia-1 (Mcl-1) Protein. Analytical Chemistry. PMID 29025262 DOI: 10.1021/Acs.Analchem.7B01148 |
0.693 |
|
| 2017 |
Xu G, Liu T, Zhou Y, Yang X, Fang H. 1-Phenyl-1H-indole derivatives as a new class of Bcl-2/Mcl-1 dual inhibitors: Design, synthesis, and preliminary biological evaluation. Bioorganic & Medicinal Chemistry. PMID 28866374 DOI: 10.1016/J.Bmc.2017.08.024 |
0.4 |
|
| 2017 |
Zhou Y, Dun Y, Fu H, Wang L, Pan X, Yang X, Fang H. Design, synthesis and preliminary bioactivity evaluation of N-benzylpyrimidin-2-amine derivatives as novel histone deacetylase (HDAC) inhibitor. Chemical Biology & Drug Design. PMID 28489276 DOI: 10.1111/Cbdd.13019 |
0.407 |
|
| 2017 |
Chen C, Hou X, Wang G, Pan W, Yang X, Zhang Y, Fang H. Design, synthesis and biological evaluation of quinoline derivatives as HDAC class I inhibitors. European Journal of Medicinal Chemistry. 133: 11-23. PMID 28371677 DOI: 10.1016/J.Ejmech.2017.03.064 |
0.395 |
|
| 2017 |
Liu T, Wan Y, Liu R, Ma L, Li M, Fang H. Design, synthesis and preliminary biological evaluation of indole-3-carboxylic acid-based skeleton of Bcl-2/Mcl-1 dual inhibitors. Bioorganic & Medicinal Chemistry. PMID 28233676 DOI: 10.1016/J.Bmc.2017.02.014 |
0.611 |
|
| 2016 |
Hou X, Rooklin D, Fang H, Zhang Y. Resveratrol serves as a protein-substrate interaction stabilizer in human SIRT1 activation. Scientific Reports. 6: 38186. PMID 27901083 DOI: 10.1038/Srep38186 |
0.328 |
|
| 2016 |
Wan Y, Liu T, Li X, Chen C, Fang H. Improved binding affinities of pyrrolidine derivatives as Mcl-1 inhibitors by modifying amino acid side chains. Bioorganic & Medicinal Chemistry. PMID 27810438 DOI: 10.1016/J.Bmc.2016.10.020 |
0.427 |
|
| 2016 |
Ge L, Li KS, Li MM, Xiao P, Hou XB, Chen X, Liu HD, Lin A, Yu X, Ren GJ, Fang H, Sun JP. Identification of a benzo imidazole thiazole derivative as the specific irreversible inhibitor of protein tyrosine phosphatase. Bioorganic & Medicinal Chemistry Letters. PMID 27554446 DOI: 10.1016/J.Bmcl.2016.08.024 |
0.393 |
|
| 2016 |
Liu R, Wang J, Tang W, Fang H. Design and synthesis of a new generation of substituted purine hydroxamate analogs as histone deacetylase inhibitors. Bioorganic & Medicinal Chemistry. PMID 26907204 DOI: 10.1016/J.Bmc.2016.02.005 |
0.418 |
|
| 2016 |
Pan X, Wang L, Dun Y, Fang H. Synthesis and Antiproliferative Activity Studies on 2-Substitued Aniline Quinazoline Derivatives Chinese Journal of Organic Chemistry. 36: 1044. DOI: 10.6023/Cjoc201510018 |
0.346 |
|
| 2016 |
Liu T, Wan Y, Liu R, Ma L, Li M, Fang H. Improved antiproliferative activities of a new series of 1,3,4-thiadiazole derivatives against human leukemia and breast cancer cell lines Chemical Research in Chinese Universities. 32: 768-774. DOI: 10.1007/S40242-016-6159-6 |
0.571 |
|
| 2015 |
Wan Y, Wang J, Sun F, Chen M, Hou X, Fang H. Design, synthesis and preliminary biological studies of pyrrolidine derivatives as Mcl-1 inhibitors. Bioorganic & Medicinal Chemistry. PMID 26620718 DOI: 10.1016/J.Bmc.2015.11.014 |
0.409 |
|
| 2015 |
Wang G, Wang Y, Wang L, Han L, Hou X, Fu H, Fang H. Design, synthesis and preliminary bioactivity studies of imidazolidine-2,4-dione derivatives as Bcl-2 inhibitors. Bioorganic & Medicinal Chemistry. PMID 26558516 DOI: 10.1016/J.Bmc.2015.10.023 |
0.373 |
|
| 2015 |
Li KS, Xiao P, Zhang DL, Hou XB, Ge L, Yang DX, Liu HD, He DF, Chen X, Han KR, Song XY, Yu X, Fang H, Sun JP. Identification of para-Substituted Benzoic Acid Derivatives as Potent Inhibitors of the Protein Phosphatase Slingshot. Chemmedchem. PMID 26553423 DOI: 10.1002/Cmdc.201500454 |
0.429 |
|
| 2015 |
Fu H, Hou X, Wang L, Dun Y, Yang X, Fang H. Design, synthesis and biological evaluation of 3-aryl-rhodanine benzoic acids as anti-apoptotic protein Bcl-2 inhibitors. Bioorganic & Medicinal Chemistry Letters. PMID 26421995 DOI: 10.1016/J.Bmcl.2015.09.051 |
0.402 |
|
| 2015 |
Hou X, Li K, Yu X, Sun JP, Fang H. Protein Flexibility in Docking-Based Virtual Screening: Discovery of Novel Lymphoid-Specific Tyrosine Phosphatase Inhibitors Using Multiple Crystal Structures. Journal of Chemical Information and Modeling. PMID 26360643 DOI: 10.1021/Acs.Jcim.5B00344 |
0.365 |
|
| 2015 |
Fu H, Han L, Hou X, Dun Y, Wang L, Gong X, Fang H. Design, synthesis and biological evaluation of saccharin-based N-hydroxybenzamides as histone deacetylases (HDACs) inhibitors. Bioorganic & Medicinal Chemistry. 23: 5774-81. PMID 26216016 DOI: 10.1016/J.Bmc.2015.07.008 |
0.362 |
|
| 2015 |
Wang L, Hou X, Fu H, Pan X, Xu W, Tang W, Fang H. Design, synthesis and preliminary bioactivity evaluations of substituted quinoline hydroxamic acid derivatives as novel histone deacetylase (HDAC) inhibitors. Bioorganic & Medicinal Chemistry. PMID 26149591 DOI: 10.1016/J.Bmc.2015.06.024 |
0.432 |
|
| 2015 |
Wan Y, Wu S, Xiao G, Liu T, Hou X, Chen C, Guan P, Yang X, Fang H. Design, synthesis and preliminary bioactivity studies of 2-thioxo-4-thiazolidinone derivatives as Bcl-2 inhibitors. Bioorganic & Medicinal Chemistry. 23: 1994-2003. PMID 25818766 DOI: 10.1016/J.Bmc.2015.03.024 |
0.387 |
|
| 2015 |
Hou X, Du J, Liu R, Zhou Y, Li M, Xu W, Fang H. Enhancing the Sensitivity of Pharmacophore-Based Virtual Screening by Incorporating Customized ZBG Features: A Case Study Using Histone Deacetylase 8. Journal of Chemical Information and Modeling. 55: 861-71. PMID 25757142 DOI: 10.1021/Ci500762Z |
0.584 |
|
| 2014 |
Hou X, Li R, Li K, Yu X, Sun JP, Fang H. Fast identification of novel lymphoid tyrosine phosphatase inhibitors using target-ligand interaction-based virtual screening. Journal of Medicinal Chemistry. 57: 9309-22. PMID 25372368 DOI: 10.1021/Jm500692U |
0.364 |
|
| 2014 |
Guan P, Wang L, Hou X, Wan Y, Xu W, Tang W, Fang H. Improved antiproliferative activity of 1,3,4-thiadiazole-containing histone deacetylase (HDAC) inhibitors by introduction of the heteroaromatic surface recognition motif. Bioorganic & Medicinal Chemistry. 22: 5766-75. PMID 25311567 DOI: 10.1016/J.Bmc.2014.09.039 |
0.353 |
|
| 2014 |
Wan Y, Liu T, Hou X, Dun Y, Guan P, Fang H. Antagonists of IAP proteins: novel anti-tumor agents. Current Medicinal Chemistry. 21: 3877-92. PMID 25174926 DOI: 10.2174/0929867321666140826115258 |
0.315 |
|
| 2014 |
Yang X, Su L, Hou X, Ding S, Xu W, Wang B, Fang H. High-performance liquid chromatographic enantioseparation of 3,5-disubstituted hydantoins analogs and temperature-induced reversals of elution orders on a polysaccharide-based chiral stationary phase. Journal of Chromatography. A. 1355: 291-5. PMID 24973033 DOI: 10.1016/J.Chroma.2014.06.022 |
0.481 |
|
| 2014 |
Fu H, Fang H, Sun J, Wang H, Liu A, Sun J, Wu Z. Boronic acid-based enzyme inhibitors: a review of recent progress. Current Medicinal Chemistry. 21: 3271-80. PMID 24934348 DOI: 10.2174/0929867321666140601200803 |
0.339 |
|
| 2014 |
Han L, Wang L, Hou X, Fu H, Song W, Tang W, Fang H. Design, synthesis and preliminary bioactivity studies of 1,2-dihydrobenzo[d]isothiazol-3-one-1,1-dioxide hydroxamic acid derivatives as novel histone deacetylase inhibitors. Bioorganic & Medicinal Chemistry. 22: 1529-38. PMID 24525003 DOI: 10.1016/J.Bmc.2014.01.045 |
0.401 |
|
| 2014 |
Wang J, Wang Q, Dun Y, Fang H. Syntheses and Antitumor Activities of Purine-sulfonamides Derivatives† Chemical Journal of Chinese Universities-Chinese. 35: 1189. DOI: 10.7503/Cjcu20131048 |
0.323 |
|
| 2014 |
Wang J, Sun F, Han L, Hou X, Pan X, Liu R, Tang W, Fang H. Design, synthesis, and preliminary bioactivity studies of substituted purine hydroxamic acid derivatives as novel histone deacetylase (HDAC) inhibitors Medchemcomm. 5: 1887-1891. DOI: 10.1039/C4Md00203B |
0.366 |
|
| 2013 |
Zhang Y, Inks ES, Zhu M, Chou CJ, Fang H, Li M, Shen Y, Yi F, Xu W. Discovery of a Pair of Diastereomers as Potent HDACs Inhibitors: Determination of Absolute Configuration, Biological Activity Comparison and Computational Study. Rsc Advances. 3. PMID 24273644 DOI: 10.1039/C3Ra43249A |
0.567 |
|
| 2013 |
Pan C, Liu HD, Gong Z, Yu X, Hou XB, Xie DD, Zhu XB, Li HW, Tang JY, Xu YF, Yu JQ, Zhang LY, Fang H, Xiao KH, Chen YG, et al. Cadmium is a potent inhibitor of PPM phosphatases and targets the M1 binding site. Scientific Reports. 3: 2333. PMID 23903585 DOI: 10.1038/Srep02333 |
0.308 |
|
| 2013 |
Su L, Jia Y, Wang X, Zhang L, Fang H, Xu W. Discovery of a synthetic Aminopeptidase N inhibitor LB-4b as a potential anticancer agent. Bioorganic & Medicinal Chemistry Letters. 23: 2512-7. PMID 23528299 DOI: 10.1016/J.Bmcl.2013.03.021 |
0.359 |
|
| 2013 |
Hou X, Du J, Zhang J, Du L, Fang H, Li M. How to improve docking accuracy of AutoDock4.2: a case study using different electrostatic potentials. Journal of Chemical Information and Modeling. 53: 188-200. PMID 23244516 DOI: 10.1021/Ci300417Y |
0.66 |
|
| 2013 |
Chen L, Sun W, Li J, Liu Z, Ma Z, Zhang W, Du L, Xu W, Fang H, Li M. The first ratiometric fluorescent probes for aminopeptidase N cell imaging. Organic & Biomolecular Chemistry. 11: 378-82. PMID 23174889 DOI: 10.1039/C2Ob26564H |
0.681 |
|
| 2013 |
Zhang X, Zhang L, Zhang J, Feng J, Yuan Y, Fang H, Xu W. Design, synthesis and preliminary activity evaluation of novel 3-amino-2-hydroxyl-3-phenylpropanoic acid derivatives as aminopeptidase N/CD13 inhibitors. Journal of Enzyme Inhibition and Medicinal Chemistry. 28: 545-51. PMID 22380779 DOI: 10.3109/14756366.2012.656622 |
0.387 |
|
| 2013 |
Chen L, Li J, Liu Z, Ma Z, Zhang W, Du L, Xu W, Fang H, Li M. A novel pH "off-on" fluorescent probe for lysosome imaging Rsc Advances. 3: 13412-13416. DOI: 10.1039/C3Ra41898G |
0.542 |
|
| 2013 |
Wang J, Wang Q, Zhang L, Fang H. Design, Synthesis and Preliminary Biological Evaluation of Purine-2,6-diamine Derivatives as Cyclin-dependent Kinase (CDK) Inhibitors Chinese Journal of Chemistry. 31: 1181-1191. DOI: 10.1002/Cjoc.201300420 |
0.353 |
|
| 2012 |
Su L, Cao J, Jia Y, Zhang X, Fang H, Xu W. Development of Synthetic Aminopeptidase N/CD13 Inhibitors to Overcome Cancer Metastasis and Angiogenesis. Acs Medicinal Chemistry Letters. 3: 959-64. PMID 24900417 DOI: 10.1021/Ml3000758 |
0.362 |
|
| 2012 |
Yang X, Hou X, Wang B, Li M, Fang H. Density functional theory based quantitative structure-property relationship studies on coumarin-based prodrugs. Bioscience Trends. 6: 234-40. PMID 23229116 DOI: 10.5582/Bst.2012.V6.5.234 |
0.628 |
|
| 2012 |
Wu Z, Li M, Fang H, Wang B. A new boronic acid based fluorescent reporter for catechol. Bioorganic & Medicinal Chemistry Letters. 22: 7179-82. PMID 23079526 DOI: 10.1016/J.Bmcl.2012.09.060 |
0.655 |
|
| 2012 |
Yao J, He Z, Chen J, Sun W, Fang H, Xu W. Design, synthesis and biological activities of sorafenib derivatives as antitumor agents. Bioorganic & Medicinal Chemistry Letters. 22: 6549-53. PMID 23021967 DOI: 10.1016/J.Bmcl.2012.09.031 |
0.391 |
|
| 2012 |
Sun W, Wu J, Li J, Fang H, Du L, Li M. Boronate can be the fluorogenic switch for the detection of hydrogen peroxide. Current Medicinal Chemistry. 19: 3622-34. PMID 22612709 DOI: 10.2174/092986712801323270 |
0.662 |
|
| 2012 |
Su L, Jia Y, Zhang L, Xu Y, Fang H, Xu W. Design, synthesis and biological evaluation of novel amino acid ureido derivatives as aminopeptidase N/CD13 inhibitors. Bioorganic & Medicinal Chemistry. 20: 3807-15. PMID 22607877 DOI: 10.1016/J.Bmc.2012.04.035 |
0.408 |
|
| 2012 |
Guan P, Sun F, Hou X, Wang F, Yi F, Xu W, Fang H. Design, synthesis and preliminary bioactivity studies of 1,3,4-thiadiazole hydroxamic acid derivatives as novel histone deacetylase inhibitors. Bioorganic & Medicinal Chemistry. 20: 3865-72. PMID 22579621 DOI: 10.1016/J.Bmc.2012.04.032 |
0.414 |
|
| 2012 |
Huang S, Jia M, Xie Y, Wang J, Xu W, Fang H. The progress of selective fluorescent chemosensors by boronic acid. Current Medicinal Chemistry. 19: 2621-37. PMID 22506769 DOI: 10.2174/092986712800493066 |
0.337 |
|
| 2012 |
Li Q, Fang H, Wang X, Hu G, Wang Q, Xu W. Novel potent 2,5-pyrrolidinedione peptidomimetics as aminopeptidase N inhibitors. Design, synthesis and activity evaluation. Bioorganic & Medicinal Chemistry Letters. 22: 850-3. PMID 22206607 DOI: 10.1016/J.Bmcl.2011.12.048 |
0.401 |
|
| 2012 |
Zhang X, Fang H, Zhang J, Yuan Y, Xu W. Recent advance in aminopeptidase N (APN/CD13) inhibitor research. Current Medicinal Chemistry. 18: 5011-21. PMID 22050749 DOI: 10.2174/092986711797535155 |
0.339 |
|
| 2012 |
Yang K, Fen J, Fang H, Zhang L, Gong J, Xu W. Synthesis of a novel series of L-isoserine derivatives as aminopeptidase N inhibitors. Journal of Enzyme Inhibition and Medicinal Chemistry. 27: 302-10. PMID 21770859 DOI: 10.3109/14756361003698147 |
0.398 |
|
| 2012 |
Wu Z, Yang X, Xu W, Wang B, Fang H. A new boronic acid-based fluorescent sensor for L-dihydroxyphenylalanine. Drug Discoveries and Therapeutics. 6: 238-241. DOI: 10.5582/Ddt.2012.V6.5.238 |
0.501 |
|
| 2012 |
Wu S, Chen M, Wang Y, Hou X, Yang X, Su L, Fang H. A facile method for the synthesis of N-(α-aminoacyl) sulfonamides. Drug Discoveries and Therapeutics. 6: 62-68. DOI: 10.5582/Ddt.2012.V6.2.62 |
0.313 |
|
| 2012 |
Chen L, Sun W, Li W, Li J, Du L, Xu W, Fang H, Li M. The first ratiometric fluorescent probe for aminopeptidase N Analytical Methods. 4: 2661-2663. DOI: 10.1039/C2Ay25556A |
0.674 |
|
| 2012 |
Liu Y, Liu X, Sun W, Fang H, Li M, Xu W. Synthesis of tert-butyl 1-(5,8-dioxohexahydro-[1,3]thiazolo[3,4-a]pyrazin-3-yl)ethylcarbamate Chemistry of Heterocyclic Compounds. 48: 950-954. DOI: 10.1007/S10593-012-1082-3 |
0.515 |
|
| 2012 |
Yao J, Chen J, He Z, Sun W, Fang H, Xu W. Thiourea and thioether derivatives of sorafenib: synthesis, crystal structure, and antiproliferative activity Medicinal Chemistry Research. 22: 3959-3968. DOI: 10.1007/S00044-012-0400-8 |
0.373 |
|
| 2012 |
Xu Y, Zhang L, Li M, Xu W, Fang H, Shang L. QSAR studies of aminopeptidase N/CD13 (APN) inhibitors with the scaffold 3-phenylpropane-1,2-diamine and molecular docking Medicinal Chemistry Research. 21: 1000-1015. DOI: 10.1007/S00044-011-9597-1 |
0.585 |
|
| 2012 |
Zhang L, Li M, Feng J, Fang H, Xu W. Discovery of a novel histone deacetylase 8 inhibitor by virtual screening Medicinal Chemistry Research. 21: 152-156. DOI: 10.1007/S00044-010-9519-7 |
0.57 |
|
| 2011 |
Chen LZ, Mou JJ, Xu YY, Fang H, Xu WF. Design, synthesis and activity study of aminopeptidase N targeted 3-amino-2-hydroxy-4-phenyl-butanoic acid derivatives. Drug Discoveries & Therapeutics. 5: 61-5. PMID 22466141 DOI: 10.5582/Ddt.2011.V5.2.61 |
0.416 |
|
| 2011 |
Zhang Y, Feng J, Jia Y, Xu Y, Liu C, Fang H, Xu W. Design, synthesis and primary activity assay of tripeptidomimetics as histone deacetylase inhibitors with linear linker and branched cap group. European Journal of Medicinal Chemistry. 46: 5387-97. PMID 21924799 DOI: 10.1016/J.Ejmech.2011.08.045 |
0.383 |
|
| 2011 |
Zhang X, Zhang J, Zhang L, Feng J, Xu Y, Yuan Y, Fang H, Xu W. Design, synthesis and biological evaluation of novel 1,2,3,4-tetrahydroisoquinoline-3-carboxylic acid derivatives as aminopeptidase N/CD13 inhibitors. Bioorganic & Medicinal Chemistry. 19: 6015-25. PMID 21911297 DOI: 10.1016/J.Bmc.2011.08.041 |
0.409 |
|
| 2011 |
Jia M, Yang K, Fang H, Xu Y, Sun S, Su L, Xu W. Novel aminopeptidase N (APN/CD13) inhibitors derived from chloramphenicol amine. Bioorganic & Medicinal Chemistry. 19: 5190-8. PMID 21802307 DOI: 10.1016/J.Bmc.2011.07.008 |
0.404 |
|
| 2011 |
Zhang Y, Feng J, Liu C, Fang H, Xu W. Design, synthesis and biological evaluation of tyrosine-based hydroxamic acid analogs as novel histone deacetylases (HDACs) inhibitors. Bioorganic & Medicinal Chemistry. 19: 4437-44. PMID 21733698 DOI: 10.1016/J.Bmc.2011.06.046 |
0.397 |
|
| 2011 |
Zhang Y, Fang H, Feng J, Jia Y, Wang X, Xu W. Discovery of a tetrahydroisoquinoline-based hydroxamic acid derivative (ZYJ-34c) as histone deacetylase inhibitor with potent oral antitumor activities. Journal of Medicinal Chemistry. 54: 5532-9. PMID 21714538 DOI: 10.1021/Jm200577A |
0.379 |
|
| 2011 |
Wang Q, Su L, Liu N, Zhang L, Xu W, Fang H. Cyclin dependent kinase 1 inhibitors: a review of recent progress. Current Medicinal Chemistry. 18: 2025-43. PMID 21517772 DOI: 10.2174/092986711795590110 |
0.307 |
|
| 2011 |
Zhang Y, Feng J, Jia Y, Wang X, Zhang L, Liu C, Fang H, Xu W. Development of tetrahydroisoquinoline-based hydroxamic acid derivatives: potent histone deacetylase inhibitors with marked in vitro and in vivo antitumor activities. Journal of Medicinal Chemistry. 54: 2823-38. PMID 21476600 DOI: 10.1021/Jm101605Z |
0.431 |
|
| 2011 |
Liu Y, Jing F, Xu Y, Xie Y, Shi F, Fang H, Li M, Xu W. Design, synthesis and biological activity of thiazolidine-4-carboxylic acid derivatives as novel influenza neuraminidase inhibitors. Bioorganic & Medicinal Chemistry. 19: 2342-8. PMID 21382719 DOI: 10.1016/J.Bmc.2011.02.019 |
0.601 |
|
| 2011 |
Xie Y, Gong J, Li M, Fang H, Xu W. The medicinal potential of influenza virus surface proteins: Hemagglutinin and neuraminidase Current Medicinal Chemistry. 18: 1050-1066. PMID 21254972 DOI: 10.2174/092986711794940815 |
0.522 |
|
| 2011 |
Luan Y, Ma C, Sui Z, Wang X, Feng J, Liu N, Jing F, Wang Y, Li M, Fang H, Xu W. LYP3, a new bestatin derivative for aminopeptidase N inhibition. Medicinal Chemistry (ShāRiqah (United Arab Emirates)). 7: 32-6. PMID 21235517 DOI: 10.2174/157340611794072706 |
0.555 |
|
| 2011 |
Su L, Fang H, Yang K, Xu Y, Xu W. Design, synthesis and biological evaluation of novel L-lysine ureido derivatives as aminopeptidase N inhibitors. Bioorganic & Medicinal Chemistry. 19: 900-6. PMID 21194957 DOI: 10.1016/J.Bmc.2010.11.066 |
0.389 |
|
| 2011 |
Zhang L, Tsai KC, Du L, Fang H, Li M, Xu W. How to generate reliable and predictive CoMFA models Current Medicinal Chemistry. 18: 923-930. PMID 21182474 DOI: 10.2174/092986711794927702 |
0.65 |
|
| 2011 |
Hou X, Du J, Fang H, Li M. 3D-QSAR study on a series of bcl-2 protein inhibitors using comparative molecular field analysis Protein and Peptide Letters. 18: 440-449. PMID 21171944 DOI: 10.2174/092986611794927992 |
0.543 |
|
| 2011 |
Liu Y, Zhang L, Gong J, Fang H, Liu A, Du G, Xu W. Design, synthesis, and biological activity of thiazole derivatives as novel influenza neuraminidase inhibitors. Journal of Enzyme Inhibition and Medicinal Chemistry. 26: 506-13. PMID 21143042 DOI: 10.3109/14756366.2010.534732 |
0.386 |
|
| 2011 |
Luan Y, Wang Q, Liu N, Mou J, Jiao X, Fang H, Li M, Xu W. Synthesis and activity evaluation of a new bestatin derivative LYP2 as an aminopeptidase N inhibitor Anti-Cancer Drugs. 22: 99-103. PMID 21048494 DOI: 10.1097/Cad.0B013E32833Ab78A |
0.573 |
|
| 2011 |
Wang X, Zhang L, Yang K, Zhang C, Zhang J, Fang H, Xu W. The effect of different species aminopeptidase N structure on the activity screening of aminopeptidase N inhibitor. Biological & Pharmaceutical Bulletin. 33: 1658-65. PMID 20930372 DOI: 10.1248/Bpb.33.1658 |
0.346 |
|
| 2011 |
Wang X, Jing F, Zhu H, Fang H, Zhang J, Xu W. Activity screening and structure-activity relationship of the hit compounds targeting APN/CD13. Fundamental & Clinical Pharmacology. 25: 217-28. PMID 20636366 DOI: 10.1111/J.1472-8206.2010.00844.X |
0.38 |
|
| 2011 |
Zhang L, Zhu H, Wang Q, Fang H, Xu W, Li M. Homology modeling, molecular dynamic simulation and docking studies of cyclin dependent kinase 1 Journal of Molecular Modeling. 17: 219-226. PMID 20419498 DOI: 10.1007/S00894-010-0710-Z |
0.537 |
|
| 2010 |
Cheng Y, Li M, Wang S, Peng H, Reid S, Ni N, Fang H, Xu W, Wang B. Carbohydrate biomarkers for future disease detection and treatment. Science China. Chemistry. 53: 3-20. PMID 32214994 DOI: 10.1007/S11426-010-0021-3 |
0.739 |
|
| 2010 |
Zhang Y, Fang H, Xu W. Applications and modifications of 1,2,3,4-tetrahydroisoquinoline-3-carboxylic acid (Tic) in peptides and peptidomimetics design and discovery. Current Protein & Peptide Science. 11: 752-8. PMID 21235510 DOI: 10.2174/138920310794557691 |
0.329 |
|
| 2010 |
Cao J, Fang H, Wang B, Ma C, Xu W. Epidermal growth factor receptor as a target for anti-cancer agent design. Anti-Cancer Agents in Medicinal Chemistry. 10: 491-503. PMID 20698825 DOI: 10.2174/1871520611009060491 |
0.487 |
|
| 2010 |
Zhang X, Fang H, Zhu H, Wang X, Zhang L, Li M, Li Q, Yuan Y, Xu W. Novel aminopeptidase N (APN/CD13) inhibitors derived from 3-phenylalanyl-N′-substituted-2,6-piperidinedione Bioorganic and Medicinal Chemistry. 18: 5981-5987. PMID 20637634 DOI: 10.1016/J.Bmc.2010.06.078 |
0.584 |
|
| 2010 |
Zhang Y, Feng J, Liu C, Zhang L, Jiao J, Fang H, Su L, Zhang X, Zhang J, Li M, Wang B, Xu W. Design, synthesis and preliminary activity assay of 1,2,3,4-tetrahydroisoquinoline-3-carboxylic acid derivatives as novel Histone deacetylases (HDACs) inhibitors. Bioorganic & Medicinal Chemistry. 18: 1761-72. PMID 20171895 DOI: 10.1016/J.Bmc.2010.01.060 |
0.675 |
|
| 2010 |
Wang Q, Xu F, Mou J, Zhang J, Shang L, Luan Y, Yuan Y, Liu Y, Li M, Fang H, Wang B, Xu W. Design, synthesis and preliminary activity evaluation of novel L-lysine derivatives as aminopeptidase N/CD13 inhibitors. Protein and Peptide Letters. 17: 847-53. PMID 20156182 DOI: 10.2174/092986610791306661 |
0.656 |
|
| 2010 |
Li Q, Fang H, Wang X, Xu W. Novel cyclic-imide peptidomimetics as aminopeptidase N inhibitors. Structure-based design, chemistry and activity evaluation. II. European Journal of Medicinal Chemistry. 45: 1618-26. PMID 20129718 DOI: 10.1016/J.Ejmech.2009.12.071 |
0.429 |
|
| 2010 |
Mou J, Fang H, Liu Y, Shang L, Wang Q, Zhang L, Xu W. Design, synthesis and primary activity assay of bi- or tri-peptide analogues with the scaffold l-arginine as amino-peptidase N/CD13 inhibitors. Bioorganic & Medicinal Chemistry. 18: 887-95. PMID 19969464 DOI: 10.1016/J.Bmc.2009.11.036 |
0.371 |
|
| 2010 |
Zhang L, Fang H, Xu W. Strategies in developing promising histone deacetylase inhibitors. Medicinal Research Reviews. 30: 585-602. PMID 19634125 DOI: 10.1002/Med.20169 |
0.347 |
|
| 2010 |
Jiao J, Fang H, Wang X, Zhu H, Jiang L, Xu W. Synthesis of a novel series of benzylether-containing cinnamoyl derivatives as histone deacetylase inhibitors. Journal of Enzyme Inhibition and Medicinal Chemistry. 25: 132-8. PMID 19558346 DOI: 10.3109/14756360903049034 |
0.384 |
|
| 2009 |
Liu N, Fang H, Li Y, Xu W. Recent research in selective cyclin-dependent kinase 4 inhibitors for anti-cancer treatment. Current Medicinal Chemistry. 16: 4869-88. PMID 19929781 DOI: 10.2174/092986709789909611 |
0.312 |
|
| 2009 |
Liu Y, Shang L, Fang H, Zhu H, Mu J, Wang Q, Wang X, Yuan Y, Xu W. Design, synthesis, and preliminary studies of the activity of novel derivatives of N-cinnamoyl-L-aspartic acid as inhibitors of aminopeptidase N/CD13. Bioorganic & Medicinal Chemistry. 17: 7398-404. PMID 19782572 DOI: 10.1016/J.Bmc.2009.07.014 |
0.408 |
|
| 2009 |
Gong J, Fang H, Li M, Liu Y, Yang K, Xu W. Potential targets and their relevant inhibitors in anti-influenza fields Current Medicinal Chemistry. 16: 3716-3739. PMID 19747144 DOI: 10.2174/092986709789104984 |
0.519 |
|
| 2009 |
Li Q, Fang H, Wang X, Hu L, Xu W. Novel cyclic-imide peptidomimetics as aminopeptidase N inhibitors. Design, chemistry and activity evaluation. Part I. European Journal of Medicinal Chemistry. 44: 4819-25. PMID 19683842 DOI: 10.1016/J.Ejmech.2009.07.022 |
0.42 |
|
| 2009 |
Jiao J, Fang H, Wang X, Guan P, Yuan Y, Xu W. Design, synthesis and preliminary biological evaluation of N-hydroxy-4-(3-phenylpropanamido)benzamide (HPPB) derivatives as novel histone deacetylase inhibitors. European Journal of Medicinal Chemistry. 44: 4470-6. PMID 19608304 DOI: 10.1016/J.Ejmech.2009.06.010 |
0.387 |
|
| 2009 |
Mou J, Fang H, Jing F, Wang Q, Liu Y, Zhu H, Shang L, Wang X, Xu W. Design, synthesis and primary activity evaluation of L-arginine derivatives as amino-peptidase N/CD13 inhibitors. Bioorganic & Medicinal Chemistry. 17: 4666-73. PMID 19454370 DOI: 10.1016/J.Bmc.2009.04.056 |
0.399 |
|
| 2009 |
Yang K, Wang Q, Su L, Fang H, Wang X, Gong J, Wang B, Xu W. Design and synthesis of novel chloramphenicol amine derivatives as potent aminopeptidase N (APN/CD13) inhibitors. Bioorganic & Medicinal Chemistry. 17: 3810-7. PMID 19423354 DOI: 10.1016/J.Bmc.2009.04.038 |
0.564 |
|
| 2009 |
Shang L, Fang H, Zhu H, Wang X, Wang Q, Mu J, Wang B, Kishioka S, Xu W. Design, synthesis and SAR studies of tripeptide analogs with the scaffold 3-phenylpropane-1,2-diamine as aminopeptidase N/CD13 inhibitors. Bioorganic & Medicinal Chemistry. 17: 2775-84. PMID 19299146 DOI: 10.1016/J.Bmc.2009.02.034 |
0.567 |
|
| 2009 |
Luan Y, Wang X, Zhu H, Qu X, Fang H, Xu W. The Synthesis and Activity Evaluation of a Bestatin Derivative (LYP) as an Aminopeptidase N Inhibitor Letters in Drug Design & Discovery. 6: 420-423. DOI: 10.2174/157018009789057535 |
0.333 |
|
| 2009 |
Zhu H, Fang H, Cheng X, Wang Q, Zhang L, Feng J, Xu W. 3D-QSAR study of pyrrolidine derivatives as matrix metalloproteinase-2 inhibitors Medicinal Chemistry Research. 18: 683-701. DOI: 10.1007/S00044-008-9160-X |
0.323 |
|
| 2008 |
Shang L, Wang Q, Fang H, Mu J, Wang X, Yuan Y, Wang B, Xu W. Novel 3-phenylpropane-1,2-diamine derivates as inhibitors of aminopeptidase N (APN). Bioorganic & Medicinal Chemistry. 16: 9984-90. PMID 18996018 DOI: 10.1016/J.Bmc.2008.10.025 |
0.559 |
|
| 2008 |
Li M, Lin N, Huang Z, Du L, Altier C, Fang H, Wang B. Selecting aptamers for a glycoprotein through the incorporation of the boronic acid moiety. Journal of the American Chemical Society. 130: 12636-8. PMID 18763762 DOI: 10.1021/Ja801510D |
0.743 |
|
| 2008 |
Cheng XC, Wang Q, Fang H, Tang W, Xu WF. Synthesis of new sulfonyl pyrrolidine derivatives as matrix metalloproteinase inhibitors. Bioorganic & Medicinal Chemistry. 16: 7932-8. PMID 18718763 DOI: 10.1016/J.Bmc.2008.07.073 |
0.327 |
|
| 2008 |
Li M, Fang H, Du L, Xia L, Wang B. Computational studies of the binding site of alpha1A-adrenoceptor antagonists. Journal of Molecular Modeling. 14: 957-66. PMID 18626669 DOI: 10.1007/S00894-008-0342-8 |
0.709 |
|
| 2008 |
Wang Q, Chen M, Zhu H, Zhang J, Fang H, Wang B, Xu W. Design, synthesis, and QSAR studies of novel lysine derives as amino-peptidase N/CD13 inhibitors. Bioorganic & Medicinal Chemistry. 16: 5473-81. PMID 18467109 DOI: 10.1016/J.Bmc.2008.04.012 |
0.565 |
|
| 2008 |
Cheng XC, Wang Q, Fang H, Tang W, Xu WF. Design, synthesis and evaluation of novel sulfonyl pyrrolidine derivatives as matrix metalloproteinase inhibitors. Bioorganic & Medicinal Chemistry. 16: 5398-404. PMID 18440232 DOI: 10.1016/J.Bmc.2008.04.027 |
0.346 |
|
| 2008 |
Zhang J, Wang Q, Fang H, Xu W, Liu A, Du G. Design, synthesis, inhibitory activity, and SAR studies of hydrophobic p-aminosalicylic acid derivatives as neuraminidase inhibitors. Bioorganic & Medicinal Chemistry. 16: 3839-47. PMID 18304821 DOI: 10.1016/J.Bmc.2008.01.036 |
0.387 |
|
| 2008 |
Xu W, Cheng X, Wang Q, Fang H. Advances in Matrix Metalloproteinase Inhibitors Based on Pyrrolidine Scaffold Current Medicinal Chemistry. 15: 374-385. DOI: 10.2174/092986708783497373 |
0.315 |
|
| 2008 |
Jiao J, Wang Q, Zhu HW, Fang H, Xu WF. Synthesis and biological evaluation of a new series of histone deacetylases inhibitors Chinese Chemical Letters. 19: 673-675. DOI: 10.1016/J.Cclet.2008.04.010 |
0.408 |
|
| 2008 |
Li YL, Fang H, Xu WF, Wang BH. New synthetic way to prepare 2-aryl-8-(piperidin-4-yl)-5,7-dimethoxy-4H-chromen-4-one as key intermediate for CDK inhibitor Chinese Chemical Letters. 19: 541-543. DOI: 10.1016/J.Cclet.2008.03.025 |
0.494 |
|
| 2007 |
Cheng XC, Wang Q, Fang H, Tang W, Xu WF. Design, synthesis and preliminary evaluation of novel pyrrolidine derivatives as matrix metalloproteinase inhibitors. European Journal of Medicinal Chemistry. 43: 2130-9. PMID 18362041 DOI: 10.1016/J.Ejmech.2007.12.020 |
0.337 |
|
| 2007 |
Liu FZ, Fang H, Zhu HW, Wang Q, Yang Y, Xu WF. Design, synthesis, and preliminary evaluation of 4-(6-(3-nitroguanidino)hexanamido)pyrrolidine derivatives as potential iNOS inhibitors. Bioorganic & Medicinal Chemistry. 16: 578-85. PMID 17937988 DOI: 10.1016/J.Bmc.2007.04.030 |
0.392 |
|
| 2007 |
Li Q, Fang H, Xu W. Novel 3-galloylamido-N'-substituted-2,6-piperidinedione-N-acetamide peptidomimetics as metalloproteinase inhibitors. Bioorganic & Medicinal Chemistry Letters. 17: 2935-8. PMID 17433673 DOI: 10.1016/J.Bmcl.2006.12.095 |
0.366 |
|
| 2007 |
Zhang J, Wang Q, Fang H, Xu W, Liu A, Du G. Design, synthesis, inhibitory activity, and SAR studies of pyrrolidine derivatives as neuraminidase inhibitors. Bioorganic & Medicinal Chemistry. 15: 2749-58. PMID 17287121 DOI: 10.1016/J.Bmc.2007.01.020 |
0.376 |
|
| 2007 |
Lin N, Yan J, Huang Z, Altier C, Li M, Carrasco N, Suyemoto M, Johnston L, Wang S, Wang Q, Fang H, Caton-Williams J, Wang B. Design and synthesis of boronic-acid-labeled thymidine triphosphate for incorporation into DNA. Nucleic Acids Research. 35: 1222-9. PMID 17267413 DOI: 10.1093/Nar/Gkl1091 |
0.67 |
|
| 2007 |
Liu FZ, Fang H, Xu WF. An efficient way to coupling amine with derivatives of steric N-Boc-pyrrolidine-2-carboxylic acid Chinese Chemical Letters. 18: 393-396. DOI: 10.1016/J.Cclet.2007.01.048 |
0.313 |
|
| 2007 |
Fang H, Li MY, Xia L. Pharmacophore-guided design, synthesis and evaluation of quinazoline-arylpiperazines as new α1-adrenoceptor antagonists Chinese Chemical Letters. 18: 41-44. DOI: 10.1016/J.Cclet.2006.11.022 |
0.343 |
|
| 2006 |
Zhang L, Zhang J, Fang H, Wang Q, Xu W. Design, synthesis and preliminary evaluation of new cinnamoyl pyrrolidine derivatives as potent gelatinase inhibitors. Bioorganic & Medicinal Chemistry. 14: 8286-94. PMID 17008101 DOI: 10.1016/J.Bmc.2006.09.015 |
0.383 |
|
| 2005 |
Yan J, Fang H, Wang B. Boronolectins and fluorescent boronolectins: an examination of the detailed chemistry issues important for the design. Medicinal Research Reviews. 25: 490-520. PMID 16025498 DOI: 10.1002/Med.20038 |
0.594 |
|
| 2005 |
Li MY, Fang H, Xia L. Pharmacophore-based design, synthesis, biological evaluation, and 3D-QSAR studies of aryl-piperazines as alpha(1)-adrenoceptor antagonists. Bioorganic & Medicinal Chemistry Letters. 15: 3216-9. PMID 15935663 DOI: 10.1016/J.Bmcl.2005.05.003 |
0.547 |
|
| 2005 |
Fang H, Kaur G, Yan J, Wang B. An Efficient Synthesis of Sterically Hindered Arylboronic Acids. Cheminform. 36. DOI: 10.1016/J.Tetlet.2005.01.064 |
0.504 |
|
| 2005 |
Fang H, Kaur G, Yan J, Wang B. An efficient synthesis of sterically hindered arylboronic acids Tetrahedron Letters. 46: 1671-1674. DOI: 10.1016/j.tetlet.2005.01.064 |
0.411 |
|
| 2004 |
Fang H, Yan J, Wang B. Biaryl product formation from cross-coupling in palladium-catalyzed borylation of a Boc protected aminobromoquinoline compound. Molecules (Basel, Switzerland). 9: 178-84. PMID 18007422 DOI: 10.3390/90300178 |
0.489 |
|
| 2004 |
Fang H, Kaur G, Wang B. Progress in boronic acid-based fluorescent glucose sensors. Journal of Fluorescence. 14: 481-9. PMID 15617256 DOI: 10.1023/B:Jofl.0000039336.51399.3B |
0.514 |
|
| 2004 |
Ni W, Fang H, Springsteen G, Wang B. The design of boronic acid spectroscopic reporter compounds by taking advantage of the pK(a)-lowering effect of diol binding: nitrophenol-based color reporters for diols. The Journal of Organic Chemistry. 69: 1999-2007. PMID 15058946 DOI: 10.1021/Jo0350357 |
0.753 |
|
| 2003 |
Yang W, Yan J, Fang H, Wang B. The first fluorescent sensor for D-glucarate based on the cooperative action of boronic acid and guanidinium groups. Chemical Communications (Cambridge, England). 792-3. PMID 12703826 DOI: 10.1039/B300098B |
0.681 |
|
| Show low-probability matches. |